

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.08509234 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.77358689 |
| 3 | heme biosynthetic process (GO:0006783) | 6.10556757 |
| 4 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.99020523 |
| 5 | tetrapyrrole biosynthetic process (GO:0033014) | 5.43493867 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.40487872 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.20016957 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.12390860 |
| 9 | regulation of female receptivity (GO:0045924) | 5.10612222 |
| 10 | female mating behavior (GO:0060180) | 4.91141195 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.87934161 |
| 12 | erythrocyte maturation (GO:0043249) | 4.83945841 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.68909731 |
| 14 | heme metabolic process (GO:0042168) | 4.66462877 |
| 15 | mature B cell differentiation involved in immune response (GO:0002313) | 4.66253998 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.64929834 |
| 17 | aggressive behavior (GO:0002118) | 4.62798564 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.59061376 |
| 19 | negative T cell selection (GO:0043383) | 4.56403785 |
| 20 | protein localization to synapse (GO:0035418) | 4.55243942 |
| 21 | porphyrin-containing compound metabolic process (GO:0006778) | 4.52888910 |
| 22 | DNA deamination (GO:0045006) | 4.52092096 |
| 23 | hyperosmotic salinity response (GO:0042538) | 4.38147624 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.37485925 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 4.22890888 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21960399 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.17781407 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.16497306 |
| 29 | sleep (GO:0030431) | 4.10979512 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.98972542 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.96430119 |
| 32 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.95783230 |
| 33 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.94157310 |
| 34 | Peyers patch development (GO:0048541) | 3.94157310 |
| 35 | erythrocyte development (GO:0048821) | 3.93840180 |
| 36 | regulation of penile erection (GO:0060405) | 3.92290407 |
| 37 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.89372270 |
| 38 | negative regulation of cell killing (GO:0031342) | 3.88755675 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88755675 |
| 40 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.87074733 |
| 41 | glutamate secretion (GO:0014047) | 3.84348439 |
| 42 | mature B cell differentiation (GO:0002335) | 3.81799990 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.80796770 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.75304001 |
| 45 | hemoglobin metabolic process (GO:0020027) | 3.75069670 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72177572 |
| 47 | maternal behavior (GO:0042711) | 3.70613003 |
| 48 | grooming behavior (GO:0007625) | 3.70017295 |
| 49 | synaptic vesicle maturation (GO:0016188) | 3.68431857 |
| 50 | amino sugar catabolic process (GO:0046348) | 3.66448633 |
| 51 | thymic T cell selection (GO:0045061) | 3.65950637 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.65173702 |
| 53 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.63764838 |
| 54 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.63036994 |
| 55 | vocalization behavior (GO:0071625) | 3.63018392 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.53354825 |
| 57 | response to insecticide (GO:0017085) | 3.51497748 |
| 58 | neuron cell-cell adhesion (GO:0007158) | 3.51113958 |
| 59 | regulation of antigen processing and presentation (GO:0002577) | 3.50842813 |
| 60 | parental behavior (GO:0060746) | 3.45819370 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.45017324 |
| 62 | positive regulation of prostaglandin secretion (GO:0032308) | 3.44886494 |
| 63 | positive T cell selection (GO:0043368) | 3.43892371 |
| 64 | locomotory exploration behavior (GO:0035641) | 3.41850812 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41707580 |
| 66 | regulation of prostaglandin secretion (GO:0032306) | 3.39155370 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.38996934 |
| 68 | T cell migration (GO:0072678) | 3.38606540 |
| 69 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.38230977 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35928923 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.34402948 |
| 72 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.31186542 |
| 73 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.30123389 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.28056612 |
| 75 | detection of bacterium (GO:0016045) | 3.27061772 |
| 76 | regulation of synapse maturation (GO:0090128) | 3.26667241 |
| 77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26545183 |
| 78 | regulation of RIG-I signaling pathway (GO:0039535) | 3.26530919 |
| 79 | purine-containing compound salvage (GO:0043101) | 3.25410806 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.23491151 |
| 81 | postsynaptic membrane organization (GO:0001941) | 3.22794223 |
| 82 | T cell selection (GO:0045058) | 3.22201244 |
| 83 | purine nucleotide salvage (GO:0032261) | 3.21675897 |
| 84 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.20852623 |
| 85 | mast cell activation (GO:0045576) | 3.17637731 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.16854983 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 3.16635178 |
| 88 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16105539 |
| 89 | L-fucose metabolic process (GO:0042354) | 3.13726138 |
| 90 | L-fucose catabolic process (GO:0042355) | 3.13726138 |
| 91 | fucose catabolic process (GO:0019317) | 3.13726138 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 3.12930095 |
| 93 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.08135338 |
| 94 | response to methylmercury (GO:0051597) | 3.07875159 |
| 95 | neurotransmitter secretion (GO:0007269) | 3.06662459 |
| 96 | leukocyte aggregation (GO:0070486) | 3.06222202 |
| 97 | detection of other organism (GO:0098543) | 3.05396776 |
| 98 | response to interleukin-15 (GO:0070672) | 3.05256301 |
| 99 | positive regulation of fibroblast migration (GO:0010763) | 3.04903436 |
| 100 | glycine transport (GO:0015816) | 3.03230662 |
| 101 | proline transport (GO:0015824) | 3.02865444 |
| 102 | transferrin transport (GO:0033572) | 3.01289081 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99562333 |
| 104 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.98043667 |
| 105 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.97774630 |
| 106 | response to auditory stimulus (GO:0010996) | 2.96200084 |
| 107 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.94878216 |
| 108 | positive regulation of membrane potential (GO:0045838) | 2.94547422 |
| 109 | mechanosensory behavior (GO:0007638) | 2.94484807 |
| 110 | tetrapyrrole metabolic process (GO:0033013) | 2.89915586 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.89756906 |
| 112 | oligosaccharide catabolic process (GO:0009313) | 2.88878443 |
| 113 | glucosamine-containing compound catabolic process (GO:1901072) | 2.88016288 |
| 114 | regulation of protein heterodimerization activity (GO:0043497) | 2.87660307 |
| 115 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86755870 |
| 116 | pigment biosynthetic process (GO:0046148) | 2.85770364 |
| 117 | tolerance induction (GO:0002507) | 2.85769156 |
| 118 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.85018286 |
| 119 | negative regulation of microtubule polymerization (GO:0031115) | 2.83893665 |
| 120 | ribosomal small subunit assembly (GO:0000028) | 2.82597002 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.80010718 |
| 122 | negative regulation of bone resorption (GO:0045779) | 2.79347442 |
| 123 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79009322 |
| 124 | exploration behavior (GO:0035640) | 2.77444098 |
| 125 | histamine secretion (GO:0001821) | 2.77148906 |
| 126 | positive regulation of T cell differentiation (GO:0045582) | 2.76029604 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.73388545 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73287130 |
| 129 | ferric iron transport (GO:0015682) | 2.71812455 |
| 130 | trivalent inorganic cation transport (GO:0072512) | 2.71812455 |
| 131 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70395403 |
| 132 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.69728575 |
| 133 | myeloid cell development (GO:0061515) | 2.69228100 |
| 134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.68505904 |
| 135 | neurotransmitter transport (GO:0006836) | 2.68063830 |
| 136 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.66884874 |
| 137 | neuromuscular process controlling posture (GO:0050884) | 2.66529112 |
| 138 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65913419 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 2.64673439 |
| 140 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.64568020 |
| 141 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.64568020 |
| 142 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.64492327 |
| 143 | regulation of synapse structural plasticity (GO:0051823) | 2.64025261 |
| 144 | leukocyte homeostasis (GO:0001776) | 2.64017527 |
| 145 | glutamate receptor signaling pathway (GO:0007215) | 2.63848336 |
| 146 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63571612 |
| 147 | T cell receptor signaling pathway (GO:0050852) | 2.63329283 |
| 148 | cellular potassium ion homeostasis (GO:0030007) | 2.63326758 |
| 149 | regulation of monocyte differentiation (GO:0045655) | 2.63304437 |
| 150 | actin filament capping (GO:0051693) | 2.63163062 |
| 151 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.62579839 |
| 152 | regulation of glutamate secretion (GO:0014048) | 2.61712968 |
| 153 | mast cell degranulation (GO:0043303) | 2.60844377 |
| 154 | mast cell activation involved in immune response (GO:0002279) | 2.60844377 |
| 155 | regulation of regulatory T cell differentiation (GO:0045589) | 2.60305602 |
| 156 | type I interferon signaling pathway (GO:0060337) | 2.59556070 |
| 157 | cellular response to type I interferon (GO:0071357) | 2.59556070 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.58895543 |
| 159 | bone resorption (GO:0045453) | 2.58881525 |
| 160 | positive regulation of lymphocyte differentiation (GO:0045621) | 2.58306547 |
| 161 | T cell costimulation (GO:0031295) | 2.58241846 |
| 162 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56450941 |
| 163 | regulation of neurotransmitter secretion (GO:0046928) | 2.55134565 |
| 164 | response to type I interferon (GO:0034340) | 2.54915911 |
| 165 | B cell mediated immunity (GO:0019724) | 2.54844176 |
| 166 | fucosylation (GO:0036065) | 2.54334820 |
| 167 | lymphocyte costimulation (GO:0031294) | 2.54111197 |
| 168 | synaptic transmission, glutamatergic (GO:0035249) | 2.53648888 |
| 169 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53625238 |
| 170 | neuron-neuron synaptic transmission (GO:0007270) | 2.53624974 |
| 171 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.53518281 |
| 172 | positive regulation of B cell proliferation (GO:0030890) | 2.53359206 |
| 173 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.52782592 |
| 174 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.52691148 |
| 175 | sodium ion export (GO:0071436) | 2.49945782 |
| 176 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.49676015 |
| 177 | long-term synaptic potentiation (GO:0060291) | 2.49573537 |
| 178 | activation of protein kinase A activity (GO:0034199) | 2.49483017 |
| 179 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.49445153 |
| 180 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.49445153 |
| 181 | neutral amino acid transport (GO:0015804) | 2.48268418 |
| 182 | long-term memory (GO:0007616) | 2.47578005 |
| 183 | DNA replication initiation (GO:0006270) | 2.46810255 |
| 184 | cerebellar granule cell differentiation (GO:0021707) | 2.45928094 |
| 185 | presynaptic membrane assembly (GO:0097105) | 2.45815149 |
| 186 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.45040469 |
| 187 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.43568710 |
| 188 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.43568710 |
| 189 | histamine transport (GO:0051608) | 2.41784288 |
| 190 | neuronal action potential propagation (GO:0019227) | 2.40884758 |
| 191 | synaptic vesicle transport (GO:0048489) | 2.39947261 |
| 192 | establishment of synaptic vesicle localization (GO:0097480) | 2.39947261 |
| 193 | neurotransmitter uptake (GO:0001504) | 2.38791744 |
| 194 | synaptic vesicle endocytosis (GO:0048488) | 2.36766220 |
| 195 | auditory behavior (GO:0031223) | 2.36748868 |
| 196 | regulation of neurotransmitter transport (GO:0051588) | 2.34140776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76160482 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32848145 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.88717820 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.45916738 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80839325 |
| 6 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.29537872 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26797981 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.19424702 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.09475628 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.05494091 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.97018215 |
| 12 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88449791 |
| 13 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.85889420 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71149214 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.66417103 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.54311479 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52830512 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.48179845 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.45371605 |
| 20 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37968003 |
| 21 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.35439811 |
| 22 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34200258 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.32198255 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.31751958 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29530779 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28279992 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.26275766 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.24533694 |
| 29 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.23977976 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 2.22428447 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18169172 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16699927 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16175058 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11246694 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10193144 |
| 36 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08875902 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07801467 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 2.03815676 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01337306 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01154879 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98020359 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.96625760 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.95432978 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.90414527 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87255551 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85681095 |
| 47 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.79746809 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79595323 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76338103 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74826386 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73642654 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73443552 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72708954 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71869907 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71758714 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70736782 |
| 57 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.68684859 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67323938 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64843961 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64207537 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.63217286 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62766183 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58863726 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57209911 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56995955 |
| 66 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56279962 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54777354 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53674810 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52756294 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52113446 |
| 71 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.51025175 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48315224 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45264758 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44301657 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39841420 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39822466 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39468461 |
| 78 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39335173 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39034942 |
| 80 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.38176933 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36811459 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35436773 |
| 83 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.34793672 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32756066 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32654962 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30746919 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29691030 |
| 88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29391285 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28916736 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28015243 |
| 91 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26509909 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23819513 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23555189 |
| 94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23505964 |
| 95 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23068016 |
| 96 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22986845 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19509762 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17910682 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17301876 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16502301 |
| 101 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16140623 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15340535 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14596440 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13540868 |
| 105 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13192587 |
| 106 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11735099 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10748703 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09849049 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09116971 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08867458 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08451335 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08155484 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07944167 |
| 114 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07817342 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05909745 |
| 116 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05536659 |
| 117 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04964515 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04863592 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03732758 |
| 120 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03440115 |
| 121 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02805647 |
| 122 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02066428 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01517582 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00798905 |
| 125 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00355706 |
| 126 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98821996 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98559722 |
| 128 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98236521 |
| 129 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97862751 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97859543 |
| 131 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97834169 |
| 132 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97638775 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97140678 |
| 134 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96891039 |
| 135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96204895 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95892512 |
| 137 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95829413 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95731027 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95564365 |
| 140 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95377635 |
| 141 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94864595 |
| 142 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94456082 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94079819 |
| 144 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93983990 |
| 145 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.92609033 |
| 146 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.90765138 |
| 147 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90666930 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90367436 |
| 149 | P68_20966046_ChIP-Seq_HELA_Human | 0.90215326 |
| 150 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90151593 |
| 151 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90124657 |
| 152 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89562693 |
| 153 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.89356900 |
| 154 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.88465824 |
| 155 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88044767 |
| 156 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87756068 |
| 157 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.87738100 |
| 158 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87648363 |
| 159 | MYC_22102868_ChIP-Seq_BL_Human | 0.87106213 |
| 160 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86458812 |
| 161 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.86325849 |
| 162 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.86084147 |
| 163 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84204404 |
| 164 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.83939698 |
| 165 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83573718 |
| 166 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.83474591 |
| 167 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81916948 |
| 168 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81915502 |
| 169 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81809989 |
| 170 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81781133 |
| 171 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81393580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 5.44662016 |
| 2 | MP0004147_increased_porphyrin_level | 5.02097219 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.32347158 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 4.15615523 |
| 5 | MP0003880_abnormal_central_pattern | 3.59407913 |
| 6 | MP0003724_increased_susceptibility_to | 3.22028405 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.01256095 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.00281120 |
| 9 | MP0002735_abnormal_chemical_nociception | 2.94877326 |
| 10 | MP0002736_abnormal_nociception_after | 2.94713584 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.89754253 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.86579473 |
| 13 | MP0003436_decreased_susceptibility_to | 2.78985570 |
| 14 | MP0001800_abnormal_humoral_immune | 2.74186020 |
| 15 | MP0009046_muscle_twitch | 2.65142970 |
| 16 | MP0005310_abnormal_salivary_gland | 2.63078349 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.60505754 |
| 18 | MP0001790_abnormal_immune_system | 2.50130912 |
| 19 | MP0005387_immune_system_phenotype | 2.50130912 |
| 20 | MP0002723_abnormal_immune_serum | 2.49678483 |
| 21 | MP0004270_analgesia | 2.46953948 |
| 22 | MP0009745_abnormal_behavioral_response | 2.46689447 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.45226322 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.45182999 |
| 25 | MP0002419_abnormal_innate_immunity | 2.45127731 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.39497855 |
| 27 | MP0001819_abnormal_immune_cell | 2.36894276 |
| 28 | MP0002064_seizures | 2.36025239 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 2.26003490 |
| 30 | MP0002063_abnormal_learning/memory/cond | 2.18130452 |
| 31 | MP0003879_abnormal_hair_cell | 2.16142776 |
| 32 | MP0000604_amyloidosis | 2.12786566 |
| 33 | MP0002272_abnormal_nervous_system | 1.96367284 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.93395657 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.92398565 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.91566924 |
| 37 | MP0001529_abnormal_vocalization | 1.84832466 |
| 38 | MP0001970_abnormal_pain_threshold | 1.83255603 |
| 39 | MP0003303_peritoneal_inflammation | 1.82943586 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.82773000 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.82531321 |
| 42 | MP0000716_abnormal_immune_system | 1.81223378 |
| 43 | MP0009785_altered_susceptibility_to | 1.80129588 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.76975250 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.70721073 |
| 46 | MP0008004_abnormal_stomach_pH | 1.70628005 |
| 47 | MP0009278_abnormal_bone_marrow | 1.66602394 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.65718402 |
| 49 | MP0009379_abnormal_foot_pigmentation | 1.61042139 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.59596843 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.58397300 |
| 52 | MP0004142_abnormal_muscle_tone | 1.58083256 |
| 53 | MP0001853_heart_inflammation | 1.58011771 |
| 54 | MP0002405_respiratory_system_inflammati | 1.57761449 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.57253948 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.54248570 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.49232251 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.47213397 |
| 59 | MP0004947_skin_inflammation | 1.46110827 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.44493496 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.44221693 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.43892355 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.43892355 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.41701344 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.40506109 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.40138749 |
| 67 | MP0001188_hyperpigmentation | 1.39671899 |
| 68 | MP0006082_CNS_inflammation | 1.38940181 |
| 69 | MP0008569_lethality_at_weaning | 1.36907210 |
| 70 | MP0002184_abnormal_innervation | 1.34840354 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.34751533 |
| 72 | MP0003329_amyloid_beta_deposits | 1.34742789 |
| 73 | MP0005423_abnormal_somatic_nervous | 1.33342482 |
| 74 | MP0001440_abnormal_grooming_behavior | 1.27669836 |
| 75 | MP0000681_abnormal_thyroid_gland | 1.25726095 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.25210088 |
| 77 | MP0008260_abnormal_autophagy | 1.20876937 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.20793009 |
| 79 | MP0002822_catalepsy | 1.18742983 |
| 80 | MP0001905_abnormal_dopamine_level | 1.18586459 |
| 81 | MP0008872_abnormal_physiological_respon | 1.16184369 |
| 82 | MP0001486_abnormal_startle_reflex | 1.14648469 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.14344755 |
| 84 | MP0001501_abnormal_sleep_pattern | 1.14320175 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.12992698 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.12742126 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.10582587 |
| 88 | MP0002933_joint_inflammation | 1.09627645 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.07816307 |
| 90 | MP0005174_abnormal_tail_pigmentation | 1.07705583 |
| 91 | MP0005636_abnormal_mineral_homeostasis | 1.07681460 |
| 92 | MP0001348_abnormal_lacrimal_gland | 1.07346202 |
| 93 | MP0003075_altered_response_to | 1.06933949 |
| 94 | MP0002166_altered_tumor_susceptibility | 1.06398448 |
| 95 | MP0008469_abnormal_protein_level | 1.05997093 |
| 96 | MP0009840_abnormal_foam_cell | 1.05584228 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 1.04884693 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 1.04073662 |
| 99 | MP0004130_abnormal_muscle_cell | 1.02858692 |
| 100 | MP0003787_abnormal_imprinting | 1.02340373 |
| 101 | MP0002398_abnormal_bone_marrow | 1.00960246 |
| 102 | MP0004924_abnormal_behavior | 1.00472748 |
| 103 | MP0005386_behavior/neurological_phenoty | 1.00472748 |
| 104 | MP0000858_altered_metastatic_potential | 0.99610341 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.99305717 |
| 106 | MP0010094_abnormal_chromosome_stability | 0.99080236 |
| 107 | MP0000490_abnormal_crypts_of | 0.97928735 |
| 108 | MP0005671_abnormal_response_to | 0.97015437 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.96949354 |
| 110 | MP0001851_eye_inflammation | 0.96769826 |
| 111 | MP0005535_abnormal_body_temperature | 0.96404746 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.94191766 |
| 113 | MP0001663_abnormal_digestive_system | 0.94110302 |
| 114 | MP0002006_tumorigenesis | 0.93967222 |
| 115 | MP0008874_decreased_physiological_sensi | 0.93879616 |
| 116 | MP0009764_decreased_sensitivity_to | 0.93387214 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.92785462 |
| 118 | MP0002090_abnormal_vision | 0.91635211 |
| 119 | MP0000955_abnormal_spinal_cord | 0.91207565 |
| 120 | MP0006035_abnormal_mitochondrial_morpho | 0.90202272 |
| 121 | MP0006292_abnormal_olfactory_placode | 0.89179934 |
| 122 | MP0005165_increased_susceptibility_to | 0.87689217 |
| 123 | MP0005166_decreased_susceptibility_to | 0.87606155 |
| 124 | MP0005645_abnormal_hypothalamus_physiol | 0.84479405 |
| 125 | MP0002882_abnormal_neuron_morphology | 0.84246382 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.83820415 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.83753478 |
| 128 | MP0000685_abnormal_immune_system | 0.82685038 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.82590970 |
| 130 | MP0005390_skeleton_phenotype | 0.82209241 |
| 131 | MP0003866_abnormal_defecation | 0.81506479 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.80680158 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.80225815 |
| 134 | MP0002148_abnormal_hypersensitivity_rea | 0.80018798 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.79329473 |
| 136 | MP0003633_abnormal_nervous_system | 0.78516881 |
| 137 | MP0002095_abnormal_skin_pigmentation | 0.77756255 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.77245759 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.75885297 |
| 140 | MP0002429_abnormal_blood_cell | 0.72543590 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.70901975 |
| 142 | MP0009763_increased_sensitivity_to | 0.70677600 |
| 143 | MP0005451_abnormal_body_composition | 0.70513557 |
| 144 | MP0004215_abnormal_myocardial_fiber | 0.70511175 |
| 145 | MP0002722_abnormal_immune_system | 0.70101590 |
| 146 | MP0005083_abnormal_biliary_tract | 0.69997558 |
| 147 | MP0002229_neurodegeneration | 0.68230871 |
| 148 | MP0004858_abnormal_nervous_system | 0.67527693 |
| 149 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65805403 |
| 150 | MP0008058_abnormal_DNA_repair | 0.65496606 |
| 151 | MP0003795_abnormal_bone_structure | 0.65115044 |
| 152 | MP0001873_stomach_inflammation | 0.65037706 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.64535060 |
| 154 | MP0008877_abnormal_DNA_methylation | 0.63870804 |
| 155 | MP0000249_abnormal_blood_vessel | 0.63559316 |
| 156 | MP0001764_abnormal_homeostasis | 0.63481171 |
| 157 | MP0003631_nervous_system_phenotype | 0.62748548 |
| 158 | MP0002163_abnormal_gland_morphology | 0.62041433 |
| 159 | MP0000358_abnormal_cell_content/ | 0.60936823 |
| 160 | MP0005025_abnormal_response_to | 0.60936505 |
| 161 | MP0001765_abnormal_ion_homeostasis | 0.60839621 |
| 162 | MP0004145_abnormal_muscle_electrophysio | 0.59389975 |
| 163 | MP0003828_pulmonary_edema | 0.57550075 |
| 164 | MP0003448_altered_tumor_morphology | 0.56195392 |
| 165 | MP0004510_myositis | 0.55409101 |
| 166 | MP0005085_abnormal_gallbladder_physiolo | 0.54217495 |
| 167 | MP0001727_abnormal_embryo_implantation | 0.52966542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.90637622 |
| 2 | Poikilocytosis (HP:0004447) | 6.16804612 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.37602476 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.37602476 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.37602476 |
| 6 | Stomatitis (HP:0010280) | 5.22945985 |
| 7 | Focal motor seizures (HP:0011153) | 4.42239287 |
| 8 | Acanthocytosis (HP:0001927) | 4.38069939 |
| 9 | Increased IgM level (HP:0003496) | 4.31429666 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.03221807 |
| 11 | Visual hallucinations (HP:0002367) | 4.02935510 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.94342795 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.72758087 |
| 14 | Reticulocytosis (HP:0001923) | 3.70598637 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.66849263 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.61567395 |
| 17 | IgG deficiency (HP:0004315) | 3.59920181 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56747973 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.56455400 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.54073783 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.51933237 |
| 22 | Abnormal number of erythroid precursors (HP:0012131) | 3.48382609 |
| 23 | Recurrent viral infections (HP:0004429) | 3.47695227 |
| 24 | Fatigue (HP:0012378) | 3.46651166 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.45945167 |
| 26 | Abnormality of T cells (HP:0002843) | 3.40610450 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.40331385 |
| 28 | Xerostomia (HP:0000217) | 3.37616704 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 3.32039105 |
| 30 | T lymphocytopenia (HP:0005403) | 3.32005125 |
| 31 | Papilledema (HP:0001085) | 3.29805046 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.27439633 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.26412453 |
| 34 | Focal seizures (HP:0007359) | 3.20526358 |
| 35 | Prostate neoplasm (HP:0100787) | 3.15935592 |
| 36 | Hepatocellular necrosis (HP:0001404) | 3.11703759 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.11389740 |
| 38 | Myokymia (HP:0002411) | 3.06976812 |
| 39 | Stomach cancer (HP:0012126) | 3.05476382 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 3.01199163 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 2.99898929 |
| 42 | B lymphocytopenia (HP:0010976) | 2.99691179 |
| 43 | Thrombocytosis (HP:0001894) | 2.96130070 |
| 44 | Hypergammaglobulinemia (HP:0010702) | 2.92276318 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.91796406 |
| 46 | Abnormality of reticulocytes (HP:0004312) | 2.89221172 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.87980313 |
| 48 | Agitation (HP:0000713) | 2.83792983 |
| 49 | Mutism (HP:0002300) | 2.81252787 |
| 50 | Febrile seizures (HP:0002373) | 2.77316791 |
| 51 | Pustule (HP:0200039) | 2.77225297 |
| 52 | Delusions (HP:0000746) | 2.75469755 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.74762484 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.73057293 |
| 55 | Petechiae (HP:0000967) | 2.71155403 |
| 56 | Leukocytosis (HP:0001974) | 2.68328031 |
| 57 | Aplastic anemia (HP:0001915) | 2.67563223 |
| 58 | Mitochondrial inheritance (HP:0001427) | 2.64435828 |
| 59 | Granulocytopenia (HP:0001913) | 2.62986733 |
| 60 | Dialeptic seizures (HP:0011146) | 2.61154119 |
| 61 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.60832349 |
| 62 | Meningitis (HP:0001287) | 2.58468595 |
| 63 | IgM deficiency (HP:0002850) | 2.58116914 |
| 64 | Myositis (HP:0100614) | 2.56688042 |
| 65 | Cholelithiasis (HP:0001081) | 2.55679840 |
| 66 | Depression (HP:0000716) | 2.54656358 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.54022830 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.53981674 |
| 69 | Loss of speech (HP:0002371) | 2.53217226 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51124411 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51124411 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51124411 |
| 73 | Colitis (HP:0002583) | 2.50314378 |
| 74 | IgA deficiency (HP:0002720) | 2.47380603 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.47179663 |
| 76 | Absence seizures (HP:0002121) | 2.46650040 |
| 77 | Gaze-evoked nystagmus (HP:0000640) | 2.46522335 |
| 78 | Cutaneous photosensitivity (HP:0000992) | 2.42028804 |
| 79 | Spondylolisthesis (HP:0003302) | 2.41638807 |
| 80 | Hepatic necrosis (HP:0002605) | 2.40966079 |
| 81 | Mediastinal lymphadenopathy (HP:0100721) | 2.40601735 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.40371126 |
| 83 | Insomnia (HP:0100785) | 2.40332163 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.39874557 |
| 85 | Pulmonary fibrosis (HP:0002206) | 2.39410974 |
| 86 | Eosinophilia (HP:0001880) | 2.39234894 |
| 87 | Protruding tongue (HP:0010808) | 2.37540381 |
| 88 | Polygenic inheritance (HP:0010982) | 2.37407783 |
| 89 | Recurrent bacterial skin infections (HP:0005406) | 2.37105166 |
| 90 | Pallor (HP:0000980) | 2.35682354 |
| 91 | Diplopia (HP:0000651) | 2.34249263 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.34249263 |
| 93 | Gingival bleeding (HP:0000225) | 2.33864934 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33493567 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.33493567 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.32685946 |
| 97 | Increased IgE level (HP:0003212) | 2.32013584 |
| 98 | Anxiety (HP:0000739) | 2.31549917 |
| 99 | Hyperventilation (HP:0002883) | 2.30492347 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.30238214 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.29059366 |
| 102 | Chronic diarrhea (HP:0002028) | 2.27407978 |
| 103 | Truncal ataxia (HP:0002078) | 2.26970515 |
| 104 | Papilloma (HP:0012740) | 2.24937927 |
| 105 | Verrucae (HP:0200043) | 2.24937927 |
| 106 | Gait imbalance (HP:0002141) | 2.22514853 |
| 107 | Lymphopenia (HP:0001888) | 2.22489438 |
| 108 | Atonic seizures (HP:0010819) | 2.22015873 |
| 109 | Vasculitis (HP:0002633) | 2.21330676 |
| 110 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20824224 |
| 111 | Impaired smooth pursuit (HP:0007772) | 2.20720114 |
| 112 | Increased CSF lactate (HP:0002490) | 2.20364628 |
| 113 | Epistaxis (HP:0000421) | 2.19856410 |
| 114 | Recurrent bronchitis (HP:0002837) | 2.19826321 |
| 115 | Episodic fever (HP:0001954) | 2.19582101 |
| 116 | Thoracic kyphosis (HP:0002942) | 2.19091289 |
| 117 | Cortical visual impairment (HP:0100704) | 2.16562926 |
| 118 | Spontaneous hematomas (HP:0007420) | 2.16054595 |
| 119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14082985 |
| 120 | Obstructive lung disease (HP:0006536) | 2.10815262 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 2.10815262 |
| 122 | Purpura (HP:0000979) | 2.10560898 |
| 123 | Hypochromic microcytic anemia (HP:0004840) | 2.09734391 |
| 124 | Osteomalacia (HP:0002749) | 2.09538022 |
| 125 | Paralysis (HP:0003470) | 2.07843194 |
| 126 | Abnormality of eosinophils (HP:0001879) | 2.07503676 |
| 127 | Acute encephalopathy (HP:0006846) | 2.06983917 |
| 128 | Gastrointestinal stroma tumor (HP:0100723) | 2.06669426 |
| 129 | Neurodegeneration (HP:0002180) | 2.06572919 |
| 130 | Recurrent skin infections (HP:0001581) | 2.05933142 |
| 131 | Postural instability (HP:0002172) | 2.05811099 |
| 132 | Acute lymphatic leukemia (HP:0006721) | 2.05122752 |
| 133 | Abnormal hair whorl (HP:0010721) | 2.05121024 |
| 134 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03958309 |
| 135 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03958309 |
| 136 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.02496933 |
| 137 | Hypothermia (HP:0002045) | 2.01770773 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 2.00270299 |
| 139 | Urticaria (HP:0001025) | 1.98506316 |
| 140 | Vacuolated lymphocytes (HP:0001922) | 1.97697926 |
| 141 | Broad-based gait (HP:0002136) | 1.96442978 |
| 142 | Hypertensive crisis (HP:0100735) | 1.95361505 |
| 143 | Recurrent lower respiratory tract infections (HP:0002783) | 1.94022356 |
| 144 | Progressive cerebellar ataxia (HP:0002073) | 1.93218578 |
| 145 | Increased hepatocellular lipid droplets (HP:0006565) | 1.92305324 |
| 146 | Genetic anticipation (HP:0003743) | 1.92166662 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91327557 |
| 148 | Supranuclear gaze palsy (HP:0000605) | 1.90978334 |
| 149 | Psychosis (HP:0000709) | 1.88589770 |
| 150 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88442765 |
| 151 | Systemic lupus erythematosus (HP:0002725) | 1.88352524 |
| 152 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87764500 |
| 153 | Chest pain (HP:0100749) | 1.87020632 |
| 154 | Diaphragmatic weakness (HP:0009113) | 1.86238486 |
| 155 | Limb ataxia (HP:0002070) | 1.85930166 |
| 156 | Increased serum lactate (HP:0002151) | 1.85843542 |
| 157 | Constricted visual fields (HP:0001133) | 1.85272598 |
| 158 | Encephalitis (HP:0002383) | 1.84927279 |
| 159 | Urethral obstruction (HP:0000796) | 1.83089249 |
| 160 | Birth length less than 3rd percentile (HP:0003561) | 1.82563618 |
| 161 | Congenital primary aphakia (HP:0007707) | 1.82367509 |
| 162 | Large eyes (HP:0001090) | 1.82310406 |
| 163 | Hydroureter (HP:0000072) | 1.81908261 |
| 164 | Poor eye contact (HP:0000817) | 1.81902913 |
| 165 | Amaurosis fugax (HP:0100576) | 1.81845049 |
| 166 | Microretrognathia (HP:0000308) | 1.81042199 |
| 167 | Prolonged bleeding time (HP:0003010) | 1.81026220 |
| 168 | Lactic acidosis (HP:0003128) | 1.81022942 |
| 169 | Poor suck (HP:0002033) | 1.80341143 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.80245642 |
| 171 | Limb dystonia (HP:0002451) | 1.76831026 |
| 172 | Nephrogenic diabetes insipidus (HP:0009806) | 1.76569700 |
| 173 | Medial flaring of the eyebrow (HP:0010747) | 1.76456577 |
| 174 | Cholecystitis (HP:0001082) | 1.73054138 |
| 175 | Abnormal gallbladder physiology (HP:0012438) | 1.73054138 |
| 176 | Microcytic anemia (HP:0001935) | 1.72466157 |
| 177 | Macrocytic anemia (HP:0001972) | 1.72297001 |
| 178 | Cellulitis (HP:0100658) | 1.71402451 |
| 179 | Dysmetric saccades (HP:0000641) | 1.70638347 |
| 180 | Abnormal eating behavior (HP:0100738) | 1.69763410 |
| 181 | Emotional lability (HP:0000712) | 1.69507658 |
| 182 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68815765 |
| 183 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66185302 |
| 184 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66185302 |
| 185 | Abnormality of alanine metabolism (HP:0010916) | 1.65351116 |
| 186 | Hyperalaninemia (HP:0003348) | 1.65351116 |
| 187 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65351116 |
| 188 | Unsteady gait (HP:0002317) | 1.64288051 |
| 189 | Polyphagia (HP:0002591) | 1.64116041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.15995027 |
| 2 | CDK19 | 3.92757134 |
| 3 | FLT3 | 3.01832675 |
| 4 | TLK1 | 2.95708812 |
| 5 | MAP3K12 | 2.91156364 |
| 6 | DAPK2 | 2.84686983 |
| 7 | DAPK1 | 2.67662531 |
| 8 | SCYL2 | 2.58234808 |
| 9 | CCNB1 | 2.56863781 |
| 10 | STK16 | 2.48787862 |
| 11 | EIF2AK1 | 2.37672665 |
| 12 | MAP3K13 | 2.34203753 |
| 13 | NME2 | 2.15340010 |
| 14 | ACVR1B | 2.11009432 |
| 15 | PRPF4B | 2.08666749 |
| 16 | PLK2 | 2.05047005 |
| 17 | MAP2K7 | 2.03777502 |
| 18 | KIT | 2.03501584 |
| 19 | MARK1 | 1.99357826 |
| 20 | PRKD3 | 1.90063526 |
| 21 | MAP3K14 | 1.86660364 |
| 22 | NEK9 | 1.83862069 |
| 23 | GRK5 | 1.82317572 |
| 24 | NEK2 | 1.82260888 |
| 25 | MATK | 1.80570851 |
| 26 | TAOK3 | 1.77783594 |
| 27 | KDR | 1.75665596 |
| 28 | TNIK | 1.72770735 |
| 29 | MINK1 | 1.71881838 |
| 30 | TESK2 | 1.69960502 |
| 31 | VRK1 | 1.67241125 |
| 32 | EEF2K | 1.64811655 |
| 33 | CAMKK2 | 1.56501219 |
| 34 | IKBKB | 1.51626508 |
| 35 | MAP2K3 | 1.50585462 |
| 36 | BRSK1 | 1.50404840 |
| 37 | BUB1 | 1.50030238 |
| 38 | MAP3K4 | 1.47453934 |
| 39 | JAK3 | 1.46766409 |
| 40 | EPHA4 | 1.46578046 |
| 41 | NTRK3 | 1.46033617 |
| 42 | FES | 1.43140459 |
| 43 | CSF1R | 1.43134841 |
| 44 | BTK | 1.43097365 |
| 45 | TYK2 | 1.42667766 |
| 46 | RIPK4 | 1.38755136 |
| 47 | ITK | 1.36512196 |
| 48 | ZAP70 | 1.33964253 |
| 49 | MAPK13 | 1.32703528 |
| 50 | SYK | 1.31782453 |
| 51 | IKBKE | 1.31101752 |
| 52 | MAPKAPK3 | 1.28655685 |
| 53 | MAPKAPK5 | 1.24479125 |
| 54 | CAMKK1 | 1.23070327 |
| 55 | MAPK7 | 1.17171386 |
| 56 | BCKDK | 1.15706029 |
| 57 | CDC7 | 1.14949453 |
| 58 | PRKD2 | 1.12919172 |
| 59 | MAP3K9 | 1.12148563 |
| 60 | LCK | 1.12010784 |
| 61 | GRK7 | 1.08380524 |
| 62 | MAP2K2 | 1.07693723 |
| 63 | IRAK3 | 1.04754136 |
| 64 | GRK6 | 0.98679690 |
| 65 | NEK1 | 0.98153106 |
| 66 | EIF2AK3 | 0.97489080 |
| 67 | PRKCH | 0.97175403 |
| 68 | TNK2 | 0.96261841 |
| 69 | PLK4 | 0.95661098 |
| 70 | BMPR1B | 0.94303806 |
| 71 | HCK | 0.89537837 |
| 72 | MAP2K4 | 0.89109898 |
| 73 | SIK2 | 0.88704719 |
| 74 | BLK | 0.88703713 |
| 75 | AKT3 | 0.85821718 |
| 76 | TGFBR1 | 0.85267916 |
| 77 | DAPK3 | 0.84584848 |
| 78 | CDK5 | 0.81467777 |
| 79 | MAP3K3 | 0.79180165 |
| 80 | NTRK2 | 0.78751441 |
| 81 | RPS6KL1 | 0.78392061 |
| 82 | RPS6KC1 | 0.78392061 |
| 83 | MAP3K6 | 0.78214401 |
| 84 | TEC | 0.77275738 |
| 85 | TSSK6 | 0.76459231 |
| 86 | ADRBK2 | 0.75721277 |
| 87 | CSK | 0.72648508 |
| 88 | ADRBK1 | 0.72290735 |
| 89 | TAOK2 | 0.70178907 |
| 90 | MAP3K1 | 0.68894879 |
| 91 | PRKCQ | 0.68416251 |
| 92 | SIK3 | 0.67672480 |
| 93 | RPS6KA6 | 0.67383520 |
| 94 | PRKCG | 0.65795403 |
| 95 | OXSR1 | 0.64878902 |
| 96 | BRAF | 0.63802823 |
| 97 | PIK3CG | 0.62600292 |
| 98 | JAK1 | 0.62223836 |
| 99 | CDK18 | 0.62182898 |
| 100 | CDK14 | 0.61949315 |
| 101 | BMPR2 | 0.61484272 |
| 102 | ERN1 | 0.60746511 |
| 103 | CAMK1 | 0.60279440 |
| 104 | CDK15 | 0.59924310 |
| 105 | CDK11A | 0.58907185 |
| 106 | DYRK2 | 0.57912552 |
| 107 | EIF2AK2 | 0.57830274 |
| 108 | CDC42BPA | 0.57155070 |
| 109 | STK4 | 0.55956538 |
| 110 | BRSK2 | 0.55559594 |
| 111 | UHMK1 | 0.54618319 |
| 112 | PKN2 | 0.54191895 |
| 113 | TESK1 | 0.52422648 |
| 114 | PIM2 | 0.51304023 |
| 115 | MAPK4 | 0.50903618 |
| 116 | MUSK | 0.47933238 |
| 117 | DYRK3 | 0.46759932 |
| 118 | PASK | 0.46628911 |
| 119 | MAPK12 | 0.44821742 |
| 120 | PIM1 | 0.44800122 |
| 121 | MAP4K1 | 0.42114644 |
| 122 | IRAK4 | 0.41017866 |
| 123 | SGK2 | 0.40837513 |
| 124 | TRPM7 | 0.38773865 |
| 125 | RET | 0.38239231 |
| 126 | ARAF | 0.38194854 |
| 127 | YES1 | 0.38009660 |
| 128 | PLK3 | 0.37208555 |
| 129 | CDK8 | 0.37084793 |
| 130 | PAK2 | 0.36576470 |
| 131 | MAP2K1 | 0.36196849 |
| 132 | AURKA | 0.35778692 |
| 133 | DYRK1B | 0.35315108 |
| 134 | LYN | 0.35101496 |
| 135 | SGK494 | 0.34960142 |
| 136 | SGK223 | 0.34960142 |
| 137 | NTRK1 | 0.34201867 |
| 138 | FGR | 0.32991451 |
| 139 | ABL2 | 0.32603847 |
| 140 | KSR2 | 0.31832408 |
| 141 | SGK3 | 0.31224221 |
| 142 | MAP3K11 | 0.31018514 |
| 143 | TAOK1 | 0.30613019 |
| 144 | WEE1 | 0.29726690 |
| 145 | NUAK1 | 0.29661659 |
| 146 | JAK2 | 0.29367195 |
| 147 | SIK1 | 0.29324844 |
| 148 | PAK6 | 0.28028347 |
| 149 | TGFBR2 | 0.27927128 |
| 150 | IRAK2 | 0.27729496 |
| 151 | PTK2B | 0.27557680 |
| 152 | INSR | 0.27093099 |
| 153 | LIMK1 | 0.27017927 |
| 154 | CDK4 | 0.26167295 |
| 155 | CLK1 | 0.26044931 |
| 156 | HIPK2 | 0.24447968 |
| 157 | PINK1 | 0.23729268 |
| 158 | TXK | 0.23609510 |
| 159 | MAPK11 | 0.23406934 |
| 160 | CHEK2 | 0.22792676 |
| 161 | RPS6KA2 | 0.22518329 |
| 162 | TBK1 | 0.22304698 |
| 163 | NME1 | 0.20857791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.62766782 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.90093044 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.61309756 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.38474175 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.28917835 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.16517194 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.91031679 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90411193 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.83992751 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.76544258 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.50485408 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35406000 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.34061088 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.31517879 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26341689 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25222542 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22148846 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19817046 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19022150 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09773726 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.08303697 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02014429 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00890071 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96149310 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.95139318 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87874702 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.86117997 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82026093 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.81105316 |
| 30 | Alcoholism_Homo sapiens_hsa05034 | 1.80472654 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.80281163 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78456843 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72187798 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.69447815 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68505055 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.63104388 |
| 37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.58619630 |
| 38 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.57010216 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.54370890 |
| 40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.51159524 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.47596799 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44914228 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44835536 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.44556014 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44161954 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41642506 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.36741781 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36472535 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36108682 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33473672 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.32899268 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32588208 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27634653 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.19099063 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17133442 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17084893 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13914265 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08725435 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06902895 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 1.05923688 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04624756 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03997667 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03072043 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.02326984 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01644279 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 1.01599648 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01253916 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 1.00203108 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.98737444 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.97600995 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.97012811 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95795354 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95411573 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.94699460 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92005220 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.90930578 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.90191991 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89091228 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.88574348 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.88505481 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88158838 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87975566 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81778568 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81426674 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81308636 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.80737011 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.80395173 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.76422387 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.76039736 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76004669 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73102560 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72839920 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71385853 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70569642 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69964622 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68804629 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67951185 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66362098 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65451738 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64064847 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62983634 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62836290 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61699398 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58856463 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58245193 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57974192 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.56346579 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.55046400 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54690686 |
| 110 | Base excision repair_Homo sapiens_hsa03410 | 0.52595875 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51737756 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48936371 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48636638 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48255042 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46988734 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46303335 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45844908 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44575298 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.44256387 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43548894 |
| 121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42887079 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41587857 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41547112 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.41005165 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40758878 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40137997 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40011605 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39641562 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39436035 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39083014 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38584950 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36600775 |
| 133 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35590000 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35361010 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35104340 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34945743 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34575596 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.34271073 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34005963 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33890269 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.33875415 |
| 142 | Hepatitis B_Homo sapiens_hsa05161 | 0.33463665 |
| 143 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32321531 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31909911 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31251004 |
| 146 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31072968 |
| 147 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30526758 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30101115 |
| 149 | Apoptosis_Homo sapiens_hsa04210 | 0.29691704 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28438538 |
| 151 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28243720 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27395818 |
| 153 | Tuberculosis_Homo sapiens_hsa05152 | 0.27321627 |
| 154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.27244270 |
| 155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27114666 |
| 156 | Spliceosome_Homo sapiens_hsa03040 | 0.26123417 |
| 157 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26003236 |
| 158 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23239372 |
| 159 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19254670 |

